Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2%
Clinical trial NCT02031445 · TERMINATED
Trial details
- NCT number
- NCT02031445
- Sponsor
- Celsus Therapeutics PLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-03-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.